Wassmann S, Werner N, Czech T, et al. Improvement of endothelial function by systemic transfusion of vascular progenitor cells[J]. Circ Res, 2006, 99(8): e74-e83. [2]Wohrle J, Birkemeyer R, Markovic S, et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease[J]. Heart, 2011, 97(16): 1338-1342. [3]Sekiguchi H, Ii M, Jujo K, et al. Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells[J]. PLoS One, 2011, 6(12): e28639. [4]Ii M, Nishimura H, Iwakura A, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity [J]. Circulation, 2005, 111(9): 1114-1120. [5]刘晓丽, 杨海捷, 苏勇, 等. E2-2基因腺病毒载体的构建及其对EPCs生长、增殖及ID1表达的影响[J]. 第三军医大学学报, 2014, 36(16): 1664-1669. [6]Morris L M, Klanke C A, Lang S A, et al. Characterization of endothelial progenitor cells mobilization following cutaneous wounding [J]. Wound Repair Regen,2010,18(4): 383-390. [7]Wang H, Yu Y, Guo R W, et al. Inhibitor of DNA binding-1 promotes the migration and proliferation of endothelial progenitor cells ？in vitro？[J]. Mol Cell Biochem, 2010, 335(1/2): 19-27. [8]Navarrete K, Pedroso I, De-Jong S, et al. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease[J]. Am J Med Genet B Neuropsychiatr Genet, 2013, 162B(1): 1-16. [9]Lazorchak A, Jones M E, Zhuang Y. New insights into E-protein function in lymphocyte development[J]. Trends Immunol, 2005, 26(6): 334-338. [10]de-Pooter R F, Kee B L. E proteins and the regulation of early lymphocyte development[J]. Immunol Rev, 2010, 238(1): 93-109. [11]Tanaka A, Itoh F, Nishiyama K, et al. Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis [J]. Blood, 2010,115(20): 4138-4147. [12]Yang W, Itoh F, Ohya H, et al. Interference of E2-2-mediated effect in endothelial cells by FAM96B through its limited expression of E2-2[J]. Cancer Sci, 2011, 102(10): 1808-1814.
[2]
李阳,倪兵.RNA干扰与人类疾病[J].第三军医大学学报,2005,27(23):2393. [2]陈新,成名翔,龚建平,等.沉默供体肝脏内核糖体蛋白S3基因减轻大鼠移植肝脏缺血再灌注损伤[J].第三军医大学学报,2011,33(14):1441. Chen Xin,Cheng Mingxiang,Gong Jianping,et al.Silencing ribosome protein S3 gene in donor livers reduces ischemia/reperfusion injury following orthotopic liver transplantation in rats[J].J Third Mil Med Univ,2011,33(22):1441. [3]熊加祥,许雪青,白云,等.载体介导的siRNA抑制B7-H1在星形胶质细胞上的表达[J].第三军医大学学报,2006,28(04):298. [4]杨媛,章波,王蒙,等.RNAi抑制IEC-6细胞中ERp29表达[J].第三军医大学学报,2006,28(11):1135. [5]星懿展,李泽桂,李红丽,等.小鼠STAT3基因干扰质粒的构建及其效果鉴定[J].第三军医大学学报,2006,28(10):1022. [6]辛海明,刘泽军,陈杰,等.iASPP特异性RNAi表达载体的构建及其干扰效果鉴定[J].第三军医大学学报,2006,28(09):900. [7]臧文巧,轩小燕,杜英,等.靶向CXCR4的siRNA对人食管鳞癌EC9706细胞裸鼠移植瘤生长的抑制作用[J].第三军医大学学报,2009,31(21):2140. ZANG Wen-qiao,XUAN Xiao-yan,DU Ying,et al.CXCR4 siRNA inhibits growth of human esophageal squamous carcinoma EC-9706 cell xenograft in nude mice[J].J Third Mil Med Univ,2009,31(22):2140. [8]耿培亮,欧娟娟,萨日娜,等.纤维粘连蛋白EDA片段调控结肠癌SW480细胞的增殖、凋亡[J].第三军医大学学报,2011,33(09):920. Geng Peiliang,Ou Juanjuan,Sa Rina,et al.Fibronectin EDA domain regulates proliferation and apoptosis of colorectal cancer SW480 cells[J].J Third Mil Med Univ,2011,33(22):920. [9]朱莹,戚华兵,王权,等.构建FGFR3基因沉默慢病毒载体及其对ATDC5细胞增殖和分化的影响[J].第三军医大学学报,2013,35(11):1043. Zhu Ying,Qi Huabing,Wang Quan,et al.Construction of lentivirus vector targeting FGFR3 gene and its effect on proliferation and differentiation in ATDC5 cells[J].J Third Mil Med Univ,2013,35(22):1043. [10]彭慧娟,张瑜,高一萌,等.Rac1蛋白在卵巢癌组织中的表达及其对卵巢癌细胞株SKOV3增殖及迁移的作用[J].第三军医大学学报,2013,35(13):1402. Peng Huijuan,Zhang Yu,Gao Yimeng,et al.Rac1 expression in ovarian cancer tissues and its role in malignant proliferation and migration of ovarian cancer cell SKOV3[J].J Third Mil Med Univ,2013,35(22):1402.
